| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 05/26/2005 | WO2004062574A9 Improved linkers for radiopharmaceutical compounds |
| 05/26/2005 | US20050113429 E.g., 4-(2-methyl-3-oxo-hept-6-en-2-yl)-2,2-dimethyl-[1,3]-dioxane chemical intermediate; chemical/metabolic stabilization of microtubuli; antitumor, -carcinogenic agents; malignant melanoma, acute lymphocytic/myelocytic leukemia; angiogenesis inhibitors; antiinflammatory/-arthritic agents; psoriasis |
| 05/26/2005 | US20050113329 Contacing cell/body fluid with antibody which binds human aspartyl (asparaginyl) beta-hydroxylase (HAAH) polypeptide; for inhibiting tumor growth; gene expression inhibition; immunization |
| 05/26/2005 | US20050113293 Cyclic and linear oligopeptides; capable of increasing gap junction conductance; lack the proarrhythmic side effects; use as drug to also treat eye disorders, cancer, and gastrointestinal disorders among others |
| 05/26/2005 | US20050112690 Binding molecules for the extra-domain B of fibronectin for detection of arteriosclerotic plaque |
| 05/26/2005 | US20050112064 DNA-dependent MRI contrast agents |
| 05/26/2005 | US20050112060 Treatment of B-cell associated diseases such as malignancies and autoimmune diseases using a cold anti-CD20 antibody/radiolabeled anti-CD22 antibody combination |
| 05/26/2005 | CA2544483A1 Soluble tcr fusion molecules and methods of use |
| 05/25/2005 | EP1532162A2 Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors |
| 05/25/2005 | EP1531874A1 Embolization |
| 05/25/2005 | EP1531873A2 Agent delivery particle |
| 05/25/2005 | EP1531859A1 Compositions and methods for transepithelial molecular transport |
| 05/25/2005 | EP0733060B1 Metal chelators |
| 05/25/2005 | DE10347459B3 Radium-Target sowie Verfahren zu seiner Herstellung Radium target, and process for its preparation |
| 05/25/2005 | CN1620454A Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 05/25/2005 | CN1620289A Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy |
| 05/25/2005 | CN1618469A Method and equipment for on-line prepn. of dopamine transport protein developer [IIC]-beta-CFT |
| 05/24/2005 | US6897209 Thrombosis; anticholesterol agents; cardiovascular disorders; antiinflammatory agents; anticancer agents |
| 05/24/2005 | US6896871 For therapy of soft tissues surrounding bone and bone-related diseases, such as bone cancer and osteoporosis |
| 05/24/2005 | US6896870 Diagnostic probes and therapeutics targeting uPA and uPAR |
| 05/19/2005 | WO2005044313A2 Conjugates of angiotensin ii and an imaging moiety |
| 05/19/2005 | WO2005019247A3 Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy |
| 05/19/2005 | US20050107583 Transport peptides for controlled delivery of substances into cells; drug delivery |
| 05/19/2005 | US20050107398 benzamide compounds labeled with detectable radionuclides that selectively bind to cancer cells, used for medical diagnosis such as tomography |
| 05/19/2005 | US20050107277 Polyalkylene polymer compounds and uses thereof |
| 05/19/2005 | US20050106620 Novel ovarian tumor antigen (OVR107) for use in diagnosis, prognosis, classification and imaging of cell proliferative disorders |
| 05/19/2005 | US20050106105 Complex of annexin and ultrasonic contrast particles or polymer |
| 05/19/2005 | US20050106102 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 05/19/2005 | US20050106100 Diagnosis, detection, monitoring a pathology condition; chelate compound labeled with metalloproteinase; cardiovascular disorders; anticancer agents; antitumor agents; antiischemic agents |
| 05/19/2005 | US20050106099 Fusion proteins |
| 05/19/2005 | DE10348319A1 Bindemoleküle für die Extra-Domäne B von Fibronectin zur Detektion von atherosklerotischen Plaques Binding molecules for the extra-domain B of fibronectin for detection of atherosclerotic plaques |
| 05/18/2005 | EP1530720A2 Breast cancer eradication program |
| 05/18/2005 | EP1530474A1 Enhancing the effect of radioimmunotherapy in the treatment of tumors |
| 05/18/2005 | EP0839055B1 Modified methioninase, its use, recombinant host cells producing high levels of methioninase and method for purifying methioninase |
| 05/18/2005 | EP0662137B1 Gene transcription and ionizing radiation: methods and compositions |
| 05/18/2005 | CN1616112A Rhenium nuclide labelled dimercapto succinic acid preparation kit and its preparing method |
| 05/18/2005 | CN1616111A Diagnostic imaging contrast agents with extended blood retention |
| 05/17/2005 | US6894046 For treating eosinophil-dependent inflammatory diseases, asthma |
| 05/17/2005 | US6893626 Compositions for TRP-M8 binding and radioreceptor methods therewith |
| 05/12/2005 | WO2005042780A1 Phage antibodies to radiation-inducible neoantigens |
| 05/12/2005 | WO2005042766A2 Technetium-99m glucarate methods of use for monitoring tissues |
| 05/12/2005 | WO2005042034A1 Peptides whose uptake by cells is controllable |
| 05/12/2005 | WO2005042033A1 Novel chemical agents comprising a cardiotonic moiety and an imaging moiety and methods of their use |
| 05/12/2005 | WO2005042029A2 Psma formulations and uses thereof |
| 05/12/2005 | WO2005042005A1 Amino acid composition with increased blood brain barrier permeability |
| 05/12/2005 | WO2005041747A2 Stealthy nano agents |
| 05/12/2005 | WO2005041656A2 Methods, compositions and devices for inducing stasis in tissues and organs |
| 05/12/2005 | WO2005041655A1 Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms |
| 05/12/2005 | US20050101524 Using arsenic oxide, or complex thereof; angiogenesis inhibitors; anticarcinogenic agents; neurodegenerative agents; antiischemic agents |
| 05/12/2005 | US20050100963 KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
| 05/12/2005 | US20050100955 Immunoglobulin direceted towards colon specific gene (CSG) for use in classification, treatment and prevention of cell proliferative disorders; diagnostic imaging; gene expression inhibition; immunotherapy |
| 05/12/2005 | US20050100918 Mammalian receptor proteins; related reagents and methods |
| 05/12/2005 | US20050100917 Mammalian receptor proteins; related reagents and methods |
| 05/12/2005 | US20050100543 Multivalent carriers of bi-specific antibodies |
| 05/12/2005 | US20050100510 Methods for using gadolinium as a contrast media |
| 05/12/2005 | US20050100509 brain image; radioisotops of benzisoxazole or benzisothiazoles; high affinity for brain acetylcholinesterase; PET or SPECT scan; 3-[2-[1-phenylmethyl)-4-piperidinyl]ethyl]-6H-pyrrolo-[3,2-f]-1,2-benzisoxazol-6-one compounds |
| 05/12/2005 | US20050100507 Chemotactic peptide antagonists for imaging sites of inflammation |
| 05/12/2005 | US20050100506 Mechanism-based targeted pancreatic beta cell imaging and therapy |
| 05/12/2005 | CA2543919A1 Peptides whose uptake by cells is controllable |
| 05/12/2005 | CA2543703A1 Psma formulations and uses thereof |
| 05/12/2005 | CA2542810A1 Methods, compositions and devices for inducing stasis in tissues and organs |
| 05/12/2005 | CA2542806A1 Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms |
| 05/11/2005 | EP1529537A1 Bifunctional tridentate pyrazolyl containing ligands for RE, TC and MN tricarbonyl complexes |
| 05/11/2005 | EP1434571B1 Particle immobilized coatings and uses thereof |
| 05/11/2005 | EP1337532B1 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit |
| 05/11/2005 | EP1068224B1 Pharmaceuticals for the imaging of angiogenic disorders |
| 05/11/2005 | EP0927049B1 Labelled elastase inhibitors |
| 05/11/2005 | EP0625200B1 Biosynthetic binding protein for cancer marker |
| 05/11/2005 | CN1201005C Antigen binding fragments that specifically detect cancer cells, nucleotindes encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/10/2005 | US6891023 Antibodies and Fv fragment recognizing antigen IOR C2 |
| 05/10/2005 | US6890950 Complex with cyclodextrins; antitumor, anticancer agents |
| 05/10/2005 | US6890907 Method of treating endobronchial infection by administering a nebulized unit dosage of an aqueous solution of tobramycin over given dosage and time, as well as specified aerosol particle sizes |
| 05/10/2005 | US6890513 Radioactive complex; medical diagnosis |
| 05/10/2005 | US6890457 Infrared radiation emitting ceramic powders comprising zirconium or radium and oxides of silicon, aluminum, iron, titanium, calcium, magnesium, potassium and sodium, used for joining wood, paper, leather, metals or plastics; radiotherapy |
| 05/10/2005 | US6890305 Conversion of carbon 13 labeled sodium bicarbonate to exhaled carbon dioxide is measured to evaluate lung function |
| 05/06/2005 | WO2005040337A2 METHODS FOR BINDING AGENTS TO β-AMYLOID PLAQUES |
| 05/06/2005 | WO2005039649A1 Radioligands for the trp-m8 receptor and methods therewith |
| 05/06/2005 | WO2005039648A2 Use of metal tricarbonyl complexes as radiotherapeutic chemotoxic agents |
| 05/06/2005 | WO2005039647A2 Radium target and method for producing it |
| 05/06/2005 | WO2005039616A1 Angiogenic peptides and uses thereof |
| 05/06/2005 | WO2005039291A2 Methods, compositions and devices for inducing stasis in cells |
| 05/06/2005 | CA2782783A1 Fused heterocyclic compounds |
| 05/06/2005 | CA2542898A1 Use of metal tricarbonyl complexes as radiotherapeutic chemotoxic agents |
| 05/06/2005 | CA2542426A1 Methods, compositions and devices for inducing stasis in cells |
| 05/06/2005 | CA2542178A1 Radium target and method for producing it |
| 05/05/2005 | US20050095201 Protein or peptide containing asparagyl-4-aminobutane and/or glutamyl-4-aminobutane residues; diagnostic magnetic resonance imaging |
| 05/05/2005 | US20050095198 Annexin derivatives with endogenous chelation sites |
| 05/05/2005 | US20050095197 Tubulin targeting drugs having positive magnetic susceptibility selectively delivered to cancer cells |
| 05/04/2005 | EP1028758B1 Radioactive compositions for the treatment of prostate tumors |
| 05/04/2005 | EP0994730B1 LABELLED FACTOR XIIIa SUBSTRATES |
| 05/04/2005 | CN1612895A Conjugates comprising an antibody specific for the ED-B domain of fibronectin and their use for the detection and treatment of tumours |
| 05/03/2005 | US6887976 Improved mammalian safety profile; glycopeptide phosphonate derivatives of invention unexpectedly exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammal; antibacterial agents |
| 05/03/2005 | US6887875 2,5-diarypyrimidine compounds |
| 05/03/2005 | US6887868 Therapeutic 5-HT ligand compounds |
| 05/03/2005 | US6887458 Bead comprising mixture of polyvinyl alcohol and platinum (and titania) isotoped by neutron radiation; anticarcinogenic and antitumor agents |
| 04/28/2005 | WO2005037312A2 Binding molecules for the extra-domain b of fibronectin, used for the detection of atherosclerotic plaques |
| 04/28/2005 | WO2005018682A3 Somatostatin analogs with inhibitory activity to growth hormone release |
| 04/28/2005 | WO2005002293A3 Cox-2-targeted imaging agents |
| 04/28/2005 | WO2004110390A3 Anti-cd74 immunoconjugates and methods |
| 04/28/2005 | WO2004064870A3 Radiolabelled tissue factor binding agent and the use thereof |